Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 93
Filtrar
1.
Transplant Proc ; 55(8): 1815-1821, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37330340

RESUMEN

BACKGROUND: Infections by SARS-CoV-2 in liver transplant recipients (LT) patients are of particular concern, notably due to perceived added risks related to immunosuppression and comorbidity burden. Current literature on this topic often relies on small, non-standardized, and geographically limited studies. This manuscript describes COVID-19 presentations and causes for elevated mortality in a large cohort of LT recipients. METHODS: This study was designed as a multicentric historical cohort, including LT recipient patients with COVID-19 in 25 study centers, with the primary endpoint being COVID-related death. We also collected demographic, clinical, and laboratory data regarding presentation and disease progression. RESULTS: Two hundred and thirty-four cases were included. The study population was predominantly male and White and had a median age of 60 years. The median time from transplantation was 2.6 years (IQR 1-6). Most patients had at least one comorbidity (189, 80.8%). Patient age (P = .04), dyspnea (P < .001), intensive care unit admission (P < .001), and mechanical ventilation (P < .001) were associated with increased mortality. Modifications of immunosuppressive therapy (P < .001), specifically the suspension of tacrolimus, maintained significance in multivariable analysis. CONCLUSIONS: Attention to risk factors and the individualization of patient care, especially regarding immunosuppression management, is crucial for delivering more precise interventions to these individuals.


Asunto(s)
COVID-19 , Trasplante de Hígado , Humanos , Masculino , Persona de Mediana Edad , Femenino , COVID-19/epidemiología , SARS-CoV-2 , Trasplante de Hígado/efectos adversos , Brasil/epidemiología , Terapia de Inmunosupresión/efectos adversos , Receptores de Trasplantes
2.
Arq Bras Cir Dig ; 33(1): e1496, 2020 Jul 08.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-32667526

RESUMEN

BACKGROUND: Incidental gallbladder cancer is defined as a cancer discovered by histological examination after cholecystectomy. It is a potentially curable disease. However, some questions related to their management remain controversial and a defined strategy is associated with better prognosis. AIM: To develop the first evidence-based consensus for management of patients with incidental gallbladder cancer in Brazil. METHODS: Sixteen questions were selected, and 36 Brazilian and International members were included to the answer them. The statements were based on current evident literature. The final report was sent to the members of the panel for agreement assessment. RESULTS: Intraoperative evaluation of the specimen, use of retrieval bags and routine histopathology is recommended. Complete preoperative evaluation is necessary and the reoperation should be performed once final staging is available. Evaluation of the cystic duct margin and routine 16b1 lymph node biopsy is recommended. Chemotherapy should be considered and chemoradiation therapy if microscopically positive surgical margins. Port site should be resected exceptionally. Staging laparoscopy before reoperation is recommended, but minimally invasive radical approach only in specialized minimally invasive hepatopancreatobiliary centers. The extent of liver resection is acceptable if R0 resection is achieved. Standard lymph node dissection is required for T2 tumors and above, but common bile duct resection is not recommended routinely. CONCLUSIONS: It was possible to prepare safe recommendations as guidance for incidental gallbladder carcinoma, addressing the most frequent topics of everyday work of digestive and general surgeons.


Asunto(s)
Neoplasias de la Vesícula Biliar , Brasil , Carcinoma , Consenso , Femenino , Humanos , Hallazgos Incidentales , Escisión del Ganglio Linfático , Estadificación de Neoplasias , Tomografía Computarizada por Tomografía de Emisión de Positrones , Estudios Retrospectivos
3.
ABCD (São Paulo, Impr.) ; 33(1): e1496, 2020.
Artículo en Inglés | LILACS | ID: biblio-1130518

RESUMEN

ABSTRACT Background: Incidental gallbladder cancer is defined as a cancer discovered by histological examination after cholecystectomy. It is a potentially curable disease. However, some questions related to their management remain controversial and a defined strategy is associated with better prognosis. Aim: To develop the first evidence-based consensus for management of patients with incidental gallbladder cancer in Brazil. Methods: Sixteen questions were selected, and 36 Brazilian and International members were included to the answer them. The statements were based on current evident literature. The final report was sent to the members of the panel for agreement assessment. Results: Intraoperative evaluation of the specimen, use of retrieval bags and routine histopathology is recommended. Complete preoperative evaluation is necessary and the reoperation should be performed once final staging is available. Evaluation of the cystic duct margin and routine 16b1 lymph node biopsy is recommended. Chemotherapy should be considered and chemoradiation therapy if microscopically positive surgical margins. Port site should be resected exceptionally. Staging laparoscopy before reoperation is recommended, but minimally invasive radical approach only in specialized minimally invasive hepatopancreatobiliary centers. The extent of liver resection is acceptable if R0 resection is achieved. Standard lymph node dissection is required for T2 tumors and above, but common bile duct resection is not recommended routinely. Conclusions: It was possible to prepare safe recommendations as guidance for incidental gallbladder carcinoma, addressing the most frequent topics of everyday work of digestive and general surgeons.


RESUMO Racional: Carcinoma incidental da vesícula biliar é definido como uma neoplasia descoberta por exame histológico após colecistectomia videolaparoscópica. É potencialmente uma doença curável. Entretanto algumas questões relacionadas ao seu manuseio permanecem controversas e uma estratégia definida está associada com melhor prognóstico. Objetivo: Desenvolver o primeiro consenso baseado em evidências para o manuseio de pacientes com carcinoma incidental da vesícula biliar no Brasil. Métodos: Dezesseis questões foram selecionadas e para responder as questões e 36 membros das sociedades brasileiras e internacionais foram incluídos. As recomendações foram baseadas em evidências da literatura atual. Um relatório final foi enviado para os membros do painel para avaliação de concordância. Resultados: Avaliação intraoperatória da peça cirúrgica, uso de bolsas para retirar a peça cirúrgica e exame histopatológico de rotina, foram recomendados. Avaliação pré-operatória completa é necessária e deve ser realizada assim que o estadiamento final esteja disponível. Avaliação da margem do ducto cístico e biópsia de rotina do linfonodo 16b1 são recomendadas. Quimioterapia deve ser considerada e quimioradioterapia indicada se a margem cirúrgica microscópica seja positiva. Os portais devem ser ressecados excepcionalmente. O estadiamento laparoscópico antes da operação é recomendado, mas o tratamento radical por abordagem minimamente invasiva deve ser realizado apenas em centros especializados em cirurgia hepatopancreatobiliar minimamente invasiva. A extensão da ressecção hepática é aceitável até que seja alcançada a ressecção R0. A linfadenectomia padrão é indicada para tumores iguais ou superiores a T2, mas a ressecção da via biliar não é recomendada de rotina. Conclusões: Recomendações seguras foram preparadas para carcinoma incidental da vesícula biliar, destacando os mais frequentes tópicos do trabalho diário do cirurgião do aparelho digestivo e hepatopancreatobiliar.


Asunto(s)
Humanos , Femenino , Neoplasias de la Vesícula Biliar , Brasil , Carcinoma , Estudios Retrospectivos , Hallazgos Incidentales , Consenso , Tomografía Computarizada por Tomografía de Emisión de Positrones , Escisión del Ganglio Linfático , Estadificación de Neoplasias
4.
Case Rep Oncol ; 10(1): 244-251, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28611638

RESUMEN

Solid organ transplantation provides life-saving therapy for patients with end-stage organ disease, and its outcomes have been improving dramatically over the past few decades. However, substantial morbidity results from chronic immunosuppressive therapy administered to prevent graft rejection. It predisposes patients to several life-threatening complications, such as opportunistic microbial infections and the development of different types of cancers. Here, we presented the case of a young man with probable Lynch syndrome, who developed an aggressive colon carcinoma after long-term immunosuppressive therapy due to a prior liver transplantation. Based on this case report, we attempt to find an answer to the question about the risk of cancer development or recurrence in patients with familial syndromes receiving long-term immunosuppressive therapy and to find out how it can be minimized. Answering these questions is particularly important, given the facts that disease course is substantially more aggressive among transplanted patients and that prognosis is poor due to lack of immunocompetence, especially in the setting of Lynch syndrome.

5.
São Paulo med. j ; São Paulo med. j;133(6): 525-530, Nov.-Dec. 2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-770149

RESUMEN

CONTEXT: Orthotopic liver transplantation (OLT) is the treatment of choice for end-stage liver disease. Cirrhosis due to hepatitis C infection is the leading indication for liver transplantation worldwide. However, patients who are given transplants because of viral liver diseases often present clinical coinfections, including hepatitis B together with hepatitis D. Currently, different strategies exist for patient management before and after liver transplantation, and these are based on different protocols developed by the specialized transplantation centers. CASE REPORT: We present a rare case of a 58-year-old man with chronic hepatitis B, C and D coinfection. The patient developed cirrhosis and hepatocellular carcinoma. His treatment comprised antiviral therapy for the three viruses and OLT. The patient's outcome was satisfactory. CONCLUSION: OLT, in association with antiviral therapy using entecavir, which was administered before and after transplantation, was effective for sustained clearance of the hepatitis B and D viruses. A recurrence of hepatitis C infection after transplantation responded successfully to standard treatment comprising peginterferon alfa-2A and ribavirin.


CONTEXTO: O transplante ortotópico de fígado (TOF) é o tratamento de escolha em pacientes com doença hepática terminal. A cirrose por hepatite C é a principal indicação de transplante hepático no mundo. No entanto, pacientes transplantados por hepatopatias virais frequentemente apresentam coinfecções, como hepatite B associada a hepatite D. Atualmente, existem diferentes estratégias de manejo em pacientes pré e pós-transplantados conforme diferentes protocolos de conduta de serviços especializados em transplante. RELATO DE CASO: Apresentamos o raro caso de um homem de 58 anos diagnosticado com as hepatites crônicas B, C e D. O paciente evoluiu com cirrose e carcinoma hepatocelular. O tratamento consistiu de terapia antiviral para os três vírus e de transplante ortotópico de fígado. O desfecho do paciente foi satisfatório. CONCLUSÃO: O transplante ortotópico de fígado, associado à terapia antiviral com entecavir antes e após o procedimento, foi eficaz na depuração sustentada dos vírus B e D. A recidiva do vírus C após o transplante respondeu com sucesso ao tratamento padrão com alfapeginterferon 2A e ribavirina.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Carcinoma Hepatocelular/cirugía , Hepatitis Viral Humana/tratamiento farmacológico , Hepatitis Viral Humana/cirugía , Cirrosis Hepática/cirugía , Neoplasias Hepáticas/cirugía , Trasplante de Hígado/métodos , Antivirales/uso terapéutico , Coinfección/tratamiento farmacológico , Coinfección/cirugía , Hepatitis B/tratamiento farmacológico , Hepatitis B/cirugía , Hepatitis C/tratamiento farmacológico , Hepatitis C/cirugía , Hepatitis D/tratamiento farmacológico , Hepatitis D/cirugía , Interferón-alfa/uso terapéutico , Cirrosis Hepática/virología , Polietilenglicoles/uso terapéutico , Proteínas Recombinantes/uso terapéutico , Recurrencia , Ribavirina/uso terapéutico , Resultado del Tratamiento
6.
Sao Paulo Med J ; 133(6): 525-30, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26176835

RESUMEN

CONTEXT: Orthotopic liver transplantation (OLT) is the treatment of choice for end-stage liver disease. Cirrhosis due to hepatitis C infection is the leading indication for liver transplantation worldwide. However, patients who are given transplants because of viral liver diseases often present clinical coinfections, including hepatitis B together with hepatitis D. Currently, different strategies exist for patient management before and after liver transplantation, and these are based on different protocols developed by the specialized transplantation centers. CASE REPORT: We present a rare case of a 58-year-old man with chronic hepatitis B, C and D coinfection. The patient developed cirrhosis and hepatocellular carcinoma. His treatment comprised antiviral therapy for the three viruses and OLT. The patient's outcome was satisfactory. CONCLUSION: OLT, in association with antiviral therapy using entecavir, which was administered before and after transplantation, was effective for sustained clearance of the hepatitis B and D viruses. A recurrence of hepatitis C infection after transplantation responded successfully to standard treatment comprising peginterferon alfa-2A and ribavirin.


Asunto(s)
Carcinoma Hepatocelular/cirugía , Hepatitis Viral Humana/tratamiento farmacológico , Hepatitis Viral Humana/cirugía , Cirrosis Hepática/cirugía , Neoplasias Hepáticas/cirugía , Trasplante de Hígado/métodos , Antivirales/uso terapéutico , Coinfección/tratamiento farmacológico , Coinfección/cirugía , Hepatitis B/tratamiento farmacológico , Hepatitis B/cirugía , Hepatitis C/tratamiento farmacológico , Hepatitis C/cirugía , Hepatitis D/tratamiento farmacológico , Hepatitis D/cirugía , Humanos , Interferón-alfa/uso terapéutico , Cirrosis Hepática/virología , Masculino , Persona de Mediana Edad , Polietilenglicoles/uso terapéutico , Proteínas Recombinantes/uso terapéutico , Recurrencia , Ribavirina/uso terapéutico , Resultado del Tratamiento
7.
Cogitare enferm ; 19(3): 597-603, jul.-set. 2014.
Artículo en Portugués | LILACS, BDENF - Enfermería | ID: lil-748050

RESUMEN

O objetivo foi identificar o papel do enfermeiro no pós-transplante renal, evidenciando os principais cuidados a essa clientela. Para tanto, foi realizada revisão integrativa em setembro de 2013, tendo como fonte quatro bases de dados, usando os descritores: Transplante Renal, Assistência de enfermagem (processos, intervenções) e Pós-Transplante. Foram identificados 110 artigos dos quais 13 cumpriram os critérios de inclusão e foram separados em três categorias: Coordenação de Enfermagem; Assistência de Enfermagem; e Educação em Saúde. A literatura aponta a abrangência e importância da atuação da enfermagem na coordenação, assistência a cur to e longo prazo, ensino e pesquisa. A Sistematização da Assistência de Enfermagem mostrou ser de grande utilidade para subsidiar as intervenções de enfermagem e melhorar as respostas clínicas. Assim, são necessários mais estudos sobre a temática, principalmente sobre o aspecto educacional da atuação de enfermagem.


The objective was to identify the role of nurses in post-renal transplant, showing the main care for these patients. For this, an integrative review was conducted in September 2013, with four databases as sources, using the key words: Renal Transplant, Nursing care (processes, interventions) and Post Transplant. 110 articles were identified, of which 13 met the inclusion criteria and were divided into three categories: Coordination of Nursing; Nursing Assistance; and Health Education. The literature points to the scope and importance of nursing coordination, care in the short and long-term, teaching and research. Nursing Care Systematization proved to be very useful to support nursing interventions and improve clinical outcomes. Thus, further studies on the subject are needed, especially on the educational aspect of nursing performance.


El objetivo fue identificar el papel del enfermero en el postransplante renal, evidenciando los principales cuidados a esa clientela. Para tanto, fue realizada revisión integrativa en septiembre de 2013, teniendo como fuente los acervos de cuatro bases de datos, usando los descriptores: Trasplante Renal, Asistencia de enfermería (procesos, intervenciones) y Postrasplante. Fueron identificados 110 artículos de los cuales 13 cumplieron los criterios de inclusión y fueron clasificados en tres categorías: Coordinación de Enfermería; Asistencia de Enfermería; y Educación en Salud. La literatura apunta la abrangencia e importancia de la actuación de la enfermería en la coordinación, asistencia en curto y largo plazo, enseñanza e investigación. La Sistematización de la Asistencia de Enfermería mostró ser de gran utilidad para subsidiar las intervenciones de enfermería y mejorar las respuestas clínicas. Así, son necesarios más estudios sobre la temática, principalmente acerca del aspecto educacional de la actuación de enfermería.


Asunto(s)
Humanos , Trasplante de Riñón , Atención de Enfermería , Proceso de Enfermería
8.
São Paulo med. j ; São Paulo med. j;132(5): 307-310, 08/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-721010

RESUMEN

CONTEXT: Renal artery aneurysm (RAA) is uncommon and usually asymptomatic, but complications like rupture or thromboembolism of the aneurysm can occur, with consequent renal infarction. Most of the clinical findings are found incidentally through imaging examinations, in investigating other diseases. Renal autotransplantation (RAT) is an alternative treatment for complex RAA, with satisfactory results described in the literature. CASE REPORT: The patient was a 48-year-old man with a history of systemic arterial hypertension, thrombocytopenia and advanced hepatosplenic schistosomiasis. He complained of right lumbar pain, which was investigated through imaging examinations (computed tomography and angiotomography). These revealed right RAA of 2.5 cm in diameter. Evaluation by the vascular surgery team found that this was untreatable using endovascular methods. The treatment performed was open right nephrectomy with kidney preservation in solution, followed by aneurysmectomy, suturing of the injured artery and kidney reimplantation in the right iliac fossa with anastomosis of the iliac vessels and ureter. The durations of the surgery and kidney ischemia were 385 and 140 minutes, respectively. The patient was discharged on the 20th postoperative day, with creatinine concentration of 1.4 mg/dL, urea 41 mg/dL, urine volume 1400 mL/24 h and ascites treated with diuretics. CONCLUSION: RAT is indicated basically in three situations: extracorporeal reconstruction of complex aneurysms of the renal pedicle, extensive ureteral injury, and conservative kidney cancer surgery in patients with a single kidney. This study presents a case of a patient with advanced liver disease and RAA that was untreatable using endovascular methods and was successfully treated using RAT. .


CONTEXTO: O aneurisma de artéria renal (AAR) é incomum e, em geral, assintomático, mas podem ocorrer complicações como rotura ou embolia de trombos do aneurisma com consequente infarto renal. A maioria dos achados clínicos é encontrada acidentalmente por exames de imagem na investigação de outras doenças. O autotransplante renal (ATR) constitui-se em alternativa de tratamento de AAR com resultados satisfatórios descritos na literatura. RELATO DE CASO: Paciente masculino, 48 anos, com histórico de hipertensão arterial sistêmica, plaquetopenia e esquistossomose hepatoesplênica avançada. Referia dor lombar direita que após exames de imagem (tomografia computadorizada e angiotomografia) revelou AAR direita com 2,5 cm de diâmetro não tratável por via endovascular após avaliação da equipe de cirurgia vascular. O tratamento realizado foi uma nefrectomia aberta direita com preservação renal em solução, seguida de aneurismectomia, sutura da artéria lesada e reimplante do rim na fossa ilíaca direita com anastomoses dos vasos ilíacos e do ureter. O tempo cirúrgico e de isquemia renal foram de 385 e 140 minutos, respectivamente. Recebeu alta hospitalar no vigésimo dia do pós-operatório, com concentrações de creatinina de 1,4 mg/dL, ureia de 41 mg/dL, volume urinário de 1400 mL/24 h e ascite tratada com diuréticos. CONCLUSÃO: O ATR está indicado basicamente em três casos: reconstrução extracorpórea de aneurismas complexos do pedículo renal, lesão ureteral extensa e cirurgia conservadora de câncer renal em pacientes com único rim. Este estudo apresenta caso de paciente com doença hepática avançada e AAR intratável por método endovascular e tratado com sucesso por ATR. .


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Aneurisma/cirugía , Trasplante de Riñón/métodos , Arteria Renal/cirugía , Aneurisma/complicaciones , Aneurisma , Nefrectomía/métodos , Arteria Renal , Esquistosomiasis/complicaciones , Tomografía Computarizada por Rayos X , Trasplante Autólogo/métodos
9.
Sao Paulo Med J ; 132(5): 307-10, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25075584

RESUMEN

CONTEXT: Renal artery aneurysm (RAA) is uncommon and usually asymptomatic, but complications like rupture or thromboembolism of the aneurysm can occur, with consequent renal infarction. Most of the clinical findings are found incidentally through imaging examinations, in investigating other diseases. Renal autotransplantation (RAT) is an alternative treatment for complex RAA, with satisfactory results described in the literature. CASE REPORT: The patient was a 48-year-old man with a history of systemic arterial hypertension, thrombocytopenia and advanced hepatosplenic schistosomiasis. He complained of right lumbar pain, which was investigated through imaging examinations (computed tomography and angiotomography). These revealed right RAA of 2.5 cm in diameter. Evaluation by the vascular surgery team found that this was untreatable using endovascular methods. The treatment performed was open right nephrectomy with kidney preservation in solution, followed by aneurysmectomy, suturing of the injured artery and kidney reimplantation in the right iliac fossa with anastomosis of the iliac vessels and ureter. The durations of the surgery and kidney ischemia were 385 and 140 minutes, respectively. The patient was discharged on the 20th postoperative day, with creatinine concentration of 1.4 mg/dL, urea 41 mg/dL, urine volume 1400 mL/24 h and ascites treated with diuretics. CONCLUSION: RAT is indicated basically in three situations: extracorporeal reconstruction of complex aneurysms of the renal pedicle, extensive ureteral injury, and conservative kidney cancer surgery in patients with a single kidney. This study presents a case of a patient with advanced liver disease and RAA that was untreatable using endovascular methods and was successfully treated using RAT.


Asunto(s)
Aneurisma/cirugía , Trasplante de Riñón/métodos , Arteria Renal/cirugía , Aneurisma/complicaciones , Aneurisma/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Nefrectomía/métodos , Arteria Renal/diagnóstico por imagen , Esquistosomiasis/complicaciones , Tomografía Computarizada por Rayos X , Trasplante Autólogo/métodos
10.
Clin Transplant ; 28(2): 198-204, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24382212

RESUMEN

Systemic-enteric drainage is currently the most common technique for pancreas transplantation (PT). A novel alternative technique, portal-duodenal drainage (PDD), has potential physiological benefits and provides improved monitoring of the pancreatic graft. The current study describes 53 solitary PT procedures (43 pancreas after kidney and 10 pancreas transplant alone) using the PDD technique over the last three yr. This method resulted in one-yr patient survival at 96% and 83% graft survival. There were five cases (9.4%) of thrombosis, in which transplantectomy and two-layer closure of the native duodenum were performed. No fistulas were observed. Here, we demonstrate that the PDD technique in PT was as safe and effective as current techniques in clinical use.


Asunto(s)
Drenaje , Duodeno/cirugía , Supervivencia de Injerto , Trasplante de Riñón , Trasplante de Páncreas , Enfermedades Pancreáticas/cirugía , Adulto , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Enfermedades Pancreáticas/mortalidad , Pancreaticoduodenectomía/mortalidad , Complicaciones Posoperatorias , Pronóstico , Tasa de Supervivencia , Adulto Joven
11.
Rev Soc Bras Med Trop ; 46(1): 119-20, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23563842

RESUMEN

Neotropical polycystic echinococcosis (NPE) is a parasitic disease caused by cestodes of Echinococcus vogeli. This parasite grows most commonly in the liver, where it produces multiples cysts that cause hepatic and vessel necrosis, infects the biliary ducts, and disseminates into the peritoneal cavity, spreading to other abdominal and thoracic organs. In cases of disseminated disease in the liver and involvement of biliary ducts or portal system, liver transplantation may be a favorable option. We present a report of the first case of liver transplantation for the treatment of advanced liver NPE caused by E. vogeli.


Asunto(s)
Equinococosis Hepática/cirugía , Trasplante de Hígado , Animales , Equinococosis Hepática/parasitología , Echinococcus/clasificación , Resultado Fatal , Humanos , Masculino , Persona de Mediana Edad
12.
Rev. Soc. Bras. Med. Trop ; Rev. Soc. Bras. Med. Trop;46(1): 119-120, Jan.-Feb. 2013. ilus
Artículo en Inglés | LILACS | ID: lil-666810

RESUMEN

Neotropical polycystic echinococcosis (NPE) is a parasitic disease caused by cestodes of Echinococcus vogeli. This parasite grows most commonly in the liver, where it produces multiples cysts that cause hepatic and vessel necrosis, infects the biliary ducts, and disseminates into the peritoneal cavity, spreading to other abdominal and thoracic organs. In cases of disseminated disease in the liver and involvement of biliary ducts or portal system, liver transplantation may be a favorable option. We present a report of the first case of liver transplantation for the treatment of advanced liver NPE caused by E. vogeli.


Asunto(s)
Animales , Humanos , Masculino , Persona de Mediana Edad , Equinococosis Hepática/cirugía , Trasplante de Hígado , Equinococosis Hepática/parasitología , Echinococcus/clasificación , Resultado Fatal
15.
Islets ; 3(6): 352-7, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21983190

RESUMEN

BACKGROUND: Many studies have evaluated whether there are characteristics related to pancreas donors and the islet isolation process that can influence pancreatic islet yield. However, this analysis has not yet been performed in Brazil, one of the world leaders in whole pancreas organ transplantation (WOPT), where pancreas allocation for pancreatic islet transplantation (PIT) has no officially defined criteria. Definition of parameters that would predict the outcome of islet isolation from local pancreas donors would be useful for defining allocation priority in Brazil. OBJECTIVE: To analyze the relationship between multiple donor-related and islet isolation variables with the total number of isolated pancreatic islet equivalents (IEQ) in a brazilian sample of pancreas donors. METHODS: Several variables were analyzed in 74 pancreata relative to the outcome of total IEQs obtained at the end of the process. RESULTS: In univariate analysis, body mass index (BMI) (p = 0.003), the presence of fatty infiltrates in the pancreas as observed during harvesting (p = 0.042) and pancreas digestion time (p = 0.046) were identified as variables related to a greater IEQ yield. In a multivariate analysis a statistically significant contribution to the variability of islet yield was found only for the BMI (p = 0.017). A ROC curve defined a BMI = 30 as a cut-off point, with pancreata from donors with BMI > 30 yielding more islets than donors with BMI < 30 (p< 0.001). CONCLUSION: These data reinforce the importance of the donor BMI as a defining parameter for successful islet isolation and establishes this variable as a potential pancreas allocation criterion in Brazil, where there is unequal competition for good quality organs between WOPT and PIT.


Asunto(s)
Trasplante de Islotes Pancreáticos/métodos , Trasplante de Páncreas/métodos , Obtención de Tejidos y Órganos/métodos , Adulto , Índice de Masa Corporal , Brasil , Femenino , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Curva ROC , Sensibilidad y Especificidad , Estadísticas no Paramétricas
16.
Clin Transplant ; 25(4): E422-9, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21554397

RESUMEN

Pancreas transplantation (PT) remains a developing practice in Latin America. From 1996 to 2009, 506 PTs were performed by our team in the following categories: simultaneous pancreas-kidney (SPK), simultaneous deceased donor pancreas and living-donor kidney (SPLK), pancreas after kidney (PAK), and pancreas transplant alone (PTA). Enteric drainage was preferred for SPK and bladder drainage for solitary PT or SPLK. Immunosuppression was with tacrolimus, mycophenolate mofetil, and steroids, and anti-lymphocytic drugs were used to induce solitary PT and SPLK. The series includes 254 SPK, 60 SPLK, 94 PAK, and 98 PTA. The one-yr patient survivals were 82% for SPK, 90% for SPLK, 95% for PTA, and 93% for PAK. The one-yr pancreas graft survivals were 70% for SPK, 86% for SPLK, 86% for PAK, and 77% for PTA. The one-yr kidney graft survivals were 77.5% for SPK and 89% for SPLK. This represents the largest reported PT series in Latin America. Results comparable to those of developed countries were achieved, with the exception of the SPK category. This has led our program to prioritize solitary PT and SPLK.


Asunto(s)
Diabetes Mellitus/terapia , Supervivencia de Injerto , Trasplante de Riñón , Trasplante de Páncreas , Donantes de Tejidos , Adolescente , Adulto , Anciano , Brasil , Niño , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias , Estudios Retrospectivos , Tasa de Supervivencia , Resultado del Tratamiento , Adulto Joven
17.
Transpl Int ; 23(6): 602-10, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20028489

RESUMEN

Antibody-mediated rejection (AMR) requires specific diagnostic tools and treatment and is associated with lower graft survival. We prospectively screened C4d in pancreas (n = 35, in 27 patients) and kidney (n = 33, in 21 patients) for cause biopsies. Serum amylase and lipase, amylasuria, fasting blood glucose (FBG) and 2-h capillary glucose (CG) were also analysed. We found that 27.3% of kidney biopsies and 43% of pancreatic biopsies showed C4d staining (66.7% and 53.3% diffuse in peritubular and interacinar capillaries respectively). Isolated exocrine dysfunction was the main indication for pancreas biopsy (54.3%) and was followed by both exocrine and endocrine dysfunctions (37.1%) and isolated endocrine dysfunction (8.6%). Laboratorial parameters were comparable between T-cell mediated rejection and AMR: amylase 151.5 vs. 149 U/l (P = 0.075), lipase 1120 vs. 1288.5 U/l (P = 0.83), amylasuria variation 46.5 vs. 61% (P = 0.97), FBG 69 vs. 97 mg/dl (P = 0.20) and 2-h CG maximum 149.5 vs. 197.5 mg/dl (P = 0.49) respectively. Amylasuria values after treatment correlated with pancreas allograft loss (P = 0.015). These data suggest that C4d staining should be routinely investigated when pancreas allograft dysfunction is present because of its high detection rate in cases of rejection.


Asunto(s)
Rechazo de Injerto/inmunología , Isoanticuerpos/sangre , Trasplante de Riñón/inmunología , Trasplante de Páncreas/inmunología , Adulto , Biopsia , Femenino , Humanos , Riñón/patología , Masculino , Páncreas/patología
18.
Clin Transplant ; 23(6): 964-7, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19719729

RESUMEN

Pancreas transplantation (PT) is a relatively uncommon therapy for non-uremic type 1 diabetes, as the severity of diabetes must warrant the risk of immunosuppression. In pediatric diabetic patients, who are less likely to display uremia because of the duration of diabetes, there is very little experience with pancreas transplantation alone (PTA). This report describes a 13-yr-old male PTA recipient. This patient was initially diagnosed with type 1 diabetes mellitus at the age of four yr. Following a multidisciplinary evaluation, PTA was found to be indicated based on a history of severe labile diabetes and hypoglycemic unawareness resulting in frequent episodes of hypoglycemia and hospital admissions. Because of the failure of medical management of the patient's diabetes, a whole organ bladder and systemic drained PTA was performed. Immunosuppression included thymoglobulin, tacrolimus, mycophenolate mofetil, and steroids. Early outcome was uneventful and patient was discharged 12 d after surgery normoglycemic and insulin-free. An episode of acute rejection (Maryland grade II) 20-d post-transplant was successfully treated with corticosteroids. A second and more severe episode of rejection (Maryland grade IV) occurred 13 months post-transplant, requiring treatment with thymoglobulin and conversion from steroid to sirolimus. On tacrolimus, sirolimus, and mycophenolic acid, he remains euglycemic and insulin-free 38 months after PTA. His quality-of-life is judged to be superior to his insulin dependent state prior to transplantation. According to the medical literature, this is the youngest patient ever to undergo PTA.


Asunto(s)
Diabetes Mellitus Tipo 1/cirugía , Trasplante de Páncreas/métodos , Adolescente , Amilasas/orina , Glucemia/metabolismo , Estudios de Seguimiento , Rechazo de Injerto/tratamiento farmacológico , Rechazo de Injerto/enzimología , Rechazo de Injerto/patología , Humanos , Inmunosupresores/uso terapéutico , Insulina/sangre , Masculino , Páncreas/patología
19.
Transplantation ; 87(6): 919-25, 2009 Mar 27.
Artículo en Inglés | MEDLINE | ID: mdl-19300197

RESUMEN

BACKGROUND: Clinical demand for liver transplant steadily grows while organs offer has reached a plateau years ago. To expand the donor liver pool, various options have been considered including acceptance of suboptimal donors and steatotic grafts, with a risk of poorer outcomes. The latter risk and its relation to the grade of liver graft steatosis have been studied in this prospective clinical study. METHODS: One hundred eighteen consecutive liver transplantation (115 patients) performed between May 2002 and March 2008 were prospectively analyzed. According to the grade of steatosis on a 2 hr postreperfusion biopsy, four groups were considered: absence (<5%) (n=34), mild (<30%) (n=40), moderate (30%-60%) (n=23), or severe steatosis (> or = 60%) (n=21). Donors and recipients demographic data, and patients and grafts survival rates were compared among the four groups. RESULTS: Eighty-four (71%) grafts presented some degree of steatosis (macrosteatosis: 19.5%, microsteatosis: 47%, mix type: 33.5%). Patient and graft survival were significant lower in the "severe steatosis" group, as a whole. Grafts with less than 30% predominant macro-, or microsteatosis also had poorer outcomes with lower patient and graft survival rates. CONCLUSION: Steatotic liver grafts were used on a large scale (71%) in this clinical series. The analysis confirms that using grafts with moderate (>30%) and severe steatosis (>60%) have a negative impact on outcomes. The authors conclude that using these grafts allow a significant increase in organ offer that counterbalances the negative outcome for patients who are not offered a transplant, and this supports the need for further clinical research.


Asunto(s)
Hígado Graso/patología , Fallo Hepático/cirugía , Trasplante de Hígado/fisiología , Donantes de Tejidos/provisión & distribución , Recolección de Tejidos y Órganos/métodos , Adulto , Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Biopsia , Cadáver , Causas de Muerte , Hígado Graso/clasificación , Femenino , Humanos , Pruebas de Función Hepática , Trasplante de Hígado/métodos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Estudios Retrospectivos , Sodio/sangre , Recolección de Tejidos y Órganos/estadística & datos numéricos
20.
Arq Bras Endocrinol Metabol ; 52(2): 355-66, 2008 Mar.
Artículo en Portugués | MEDLINE | ID: mdl-18438547

RESUMEN

Pancreas and kidney transplants have specific indications, benefits and risks. The procedure has become more common and more often as long-term success has improved and risks have decreased. Compared with a patient being on dialysis, simultaneous pancreas-kidney transplant offers a distinct advantage when it comes to mortality, quality of life and diabetic complications. Since there can be a living-donor kidney transplant,, a possibly similar patient and graft survival by 10 years follow-up, this procedure should be considered. Pancreas after kidney transplants, when successful, can improve microvascular complications compared with kidney transplant alone, but immediate mortality may be higher. Solitary pancreas transplantation can improve the quality of life in selected patients, but it may also increase the immediate risk of mortality due to the complexity of the surgery and the risks of immunosupression. The results of Islet transplantation differ from the higher metabolic performance achieved by whole pancreas allotransplantation and its applicability is limited to selected adult diabetic patients.


Asunto(s)
Diabetes Mellitus Tipo 1/cirugía , Trasplante de Islotes Pancreáticos/métodos , Trasplante de Riñón/métodos , Trasplante de Páncreas/métodos , Adulto , Enfermedad Crónica , Diabetes Mellitus Tipo 1/mortalidad , Angiopatías Diabéticas/etiología , Angiopatías Diabéticas/mortalidad , Nefropatías Diabéticas/etiología , Nefropatías Diabéticas/mortalidad , Neuropatías Diabéticas/etiología , Neuropatías Diabéticas/mortalidad , Rechazo de Injerto , Humanos , Terapia de Inmunosupresión , Trasplante de Islotes Pancreáticos/efectos adversos , Trasplante de Islotes Pancreáticos/mortalidad , Trasplante de Riñón/efectos adversos , Páncreas/irrigación sanguínea , Trasplante de Páncreas/efectos adversos , Trasplante de Páncreas/mortalidad , Tasa de Supervivencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA